TY - JOUR
T1 - Spinocerebellar ataxia type 6 family with phenotypic overlap with Multiple System Atrophy
AU - Al-Shaikh, Rana Hanna
AU - Wernick, Anna I.
AU - Strongosky, Audrey J.
AU - Soto-Beasley, Alexandra I.
AU - Van Gerpen, Jay A.
AU - Cheshire, William P.
AU - Uitti, Ryan J.
AU - Ross, Owen A.
AU - Wszolek, Zbigniew K.
N1 - Funding Information:
Disclosures: Dr Hanna Al Shaikh: Receives funding from the Donald G. and Jodi P. Heeringa Family. Dr Ross: Is partially supported by R01-NS078086, P50-NS072187, U54 NS100693, U54 NS110435, Department of Defense, and the Michael J. Fox Foundation. He is an editorial board member for the American Journal of Neurodegenerative Disease, Frontiers in Neurology: Neurogenetics, and Molecular Neurodegeneration. Dr Wszolek: Is partially supported by the Mayo Clinic Centre for Regenerative Medicine, gifts from The Sol Goldman Charitable Trust, and the Donald G. and Jodi P. Heeringa Family, the Haworth Family Professorship in Neurodegenerative Diseases Fund, and the Albertson Parkinson’s Research Foundation. He serves as PI or Co-PI on grants from Abbvie, Inc (M15-562 and M15-563), Biogen, Inc (228PD201), and Biohaven Pharmaceuticals, Inc (BHV4157-206 and BHV3241-301). He serves as PI of the Mayo Clinic American Parkinson’s Disease Association Information and Referral Centre. Dr Cheshire, Ms. Wernick, Mrs. Strongosky, Mrs. Soto-Beasley, Dr van Gerpen and Dr Uitti report no disclosures. Acknowledgments: We would like to thank our patient and her family for their co-operation and support for this research study. We would also like to thank our collaborators and partners in the lab for taking the time to verify all blood samples and their continuous efforts in this research endeavour. Mayo Clinic is an American Parkinson’s Disease Association (APDA) Information and Referral Centre, an APDA Centre for Advanced Research, and a Lewy Body Dementia Association Research Centre of Excellence. Dr. Wszolek serves as Co-Editor-in-Chief of Neurologia i Neurochirurgia Polska. This manuscript processing was performed by Dr. Sławek, the second Co-Editor-in-Chief of journal.
Publisher Copyright:
© 2020 Urban and Partner. All rights reserved.
PY - 2020/8/31
Y1 - 2020/8/31
N2 - Aim of the study. Multiple system atrophy (MSA) and spinocerebellar ataxia (SCA) share similar symptomatology. We describe a rare occurrence of familial MSA that proved to be SCA6 upon genetic analysis. Materials and methods. Eighty MSA patients were enrolled in our study; blood samples were collected and genetic screening of the familial case for known SCA loci was performed. Results. A 68-year-old woman presented with recurrent and severe episodes of light-headedness, imbalance, frequent falls, neck and lower back stiffness, subjective arm and leg weakness, and numbness and tingling in both feet. One year later, her condition had declined; she experienced more falls, worsening instability, again more generalised but still subjective weakness, impaired fine motor movements, slurred speech, difficulty swallowing, episodes of choking, bladder incontinence, and constipation. Clinical suspicion included parkinsonism, MSA, and SCA. The patient was enrolled in our MSA study and was found to have 22 and 12 CAG repeats in CACNA1A. The other 79 clinical MSA patients were negative for SCA6 screening. Conclusions and clinical implications. While MSA and SCA may have similar presentations during early disease stages, the presence of both conditions on the list of differential diagnoses can be a diagnostic dilemma. Further analysis will aid in developing a biomarker to distinguish between the two conditions and guide proper management.
AB - Aim of the study. Multiple system atrophy (MSA) and spinocerebellar ataxia (SCA) share similar symptomatology. We describe a rare occurrence of familial MSA that proved to be SCA6 upon genetic analysis. Materials and methods. Eighty MSA patients were enrolled in our study; blood samples were collected and genetic screening of the familial case for known SCA loci was performed. Results. A 68-year-old woman presented with recurrent and severe episodes of light-headedness, imbalance, frequent falls, neck and lower back stiffness, subjective arm and leg weakness, and numbness and tingling in both feet. One year later, her condition had declined; she experienced more falls, worsening instability, again more generalised but still subjective weakness, impaired fine motor movements, slurred speech, difficulty swallowing, episodes of choking, bladder incontinence, and constipation. Clinical suspicion included parkinsonism, MSA, and SCA. The patient was enrolled in our MSA study and was found to have 22 and 12 CAG repeats in CACNA1A. The other 79 clinical MSA patients were negative for SCA6 screening. Conclusions and clinical implications. While MSA and SCA may have similar presentations during early disease stages, the presence of both conditions on the list of differential diagnoses can be a diagnostic dilemma. Further analysis will aid in developing a biomarker to distinguish between the two conditions and guide proper management.
KW - Cerebellum
KW - Gait disorders/ataxia
KW - SCA
KW - Spinocerebellar ataxia
UR - http://www.scopus.com/inward/record.url?scp=85090250852&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090250852&partnerID=8YFLogxK
U2 - 10.5603/PJNNS.a2020.0053
DO - 10.5603/PJNNS.a2020.0053
M3 - Article
C2 - 32687595
AN - SCOPUS:85090250852
SN - 0028-3843
VL - 54
SP - 350
EP - 355
JO - Neurologia i Neurochirurgia Polska
JF - Neurologia i Neurochirurgia Polska
IS - 4
ER -